
About Indo Amines Limited
Data last updated:
Indo Amines Limited is a public limited company based in Thane, Maharashtra, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 17 December 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L99999MH1992PLC070022. Its GSTIN is 27AAACI1374A1Z3 (Maharashtra). The company holds 3 GST registrations, all of them active. It is a listed company as per MCA records. Its shares are listed on BSE: 524648 and NSE: INDOAMIN.
The company has an authorised share capital of ₹51.14 Cr and a paid-up capital of ₹36.29 Cr. It is led by directors including Vijay Bhalchandra Palkar (Managing Director) and Rahul Vijay Palkar (Managing Director).
Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at W – 44 MIDC Phase II Dombivli (E) Dist Thane, Maharashtra, India – 421203.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹1,159.66 Cr, a growth of 7.5% compared to the previous year. For the same year it recorded a net profit of ₹79.32 Cr (net margin 6.8%) and EBITDA of ₹122.77 Cr (EBITDA margin 10.6%). The net worth stands at ₹392.34 Cr (up 23.8% YoY). Total assets are valued at ₹707 Cr (up 16.8% YoY).
The company has about 558 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 2 brands: Indo Amines Ltd and Indo Amines. As per MCA filings, the company has open charges of ₹636.94 Cr and satisfied charges of ₹201.05 Cr on record. Court records list 159 cases involving the company, including 88 filed by the company and 72 filed against it; 62 cases are pending. The company has 11 deals on record (11 market trades); the latest was in December 2024. Its 9 peer companies in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 5 smaller; the largest is Grauer and Weil (India) Limited with revenue of ₹1,180.04 Cr. The company has 14 MSME Form 1 returns on record between 2019 and 2024, listing 1,204 overdue payments to 72 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website indoaminesltd.com.
Company details
Contact details
Indo Amines Limited's registered office is in Thane, Maharashtra. Its website is indoaminesltd.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressW – 44 MIDC Phase II Dombivli (E) Dist Thane, Maharashtra, India – 421203
- IndustryChemicals and Materials, Specialty Chemicals
To see the full contact details of Indo Amines Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Indo Amines operates two associated brands: Indo Amines Ltd and Indo Amines. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Aliphatic and aromatic amines are manufactured by Indo Amines. | indoaminesltd.com | |
| Chemical manufacturing, including fine, specialty, and performance chemicals for global markets. | corechemicals.com |
Business activity
The main business activity of Indo Amines is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Indo Amines Limited, buy the company report.
Financials of Indo Amines Limited
FY 2025-26 filings availableIndo Amines Limited reported revenue of ₹1,159.66 Cr (up 7.5% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 1,160 | 1,079 | 943 | 945 | 786 | 541 | 479 |
| Revenue growth | +7.5% | +14.3% | -0.2% | +20.2% | +45.4% | +12.9% | - |
| EBITDA | 123 | 101 | 80.10 | 87.12 | 52.22 | 61.33 | 42.14 |
| EBITDA margin | +10.6% | +9.4% | +8.5% | +9.2% | +6.6% | +11.4% | +8.8% |
| Profit before tax | 106 | 76.96 | 58.27 | 56.80 | 34.52 | 48.99 | 18.34 |
| Net profit | 79.32 | 55.27 | 41.02 | 40.42 | 22.77 | 37.42 | 12.80 |
| Net profit margin | +6.8% | +5.1% | +4.4% | +4.3% | +2.9% | +6.9% | +2.7% |
| EPS (₹) | 10.79 | 7.61 | 5.89 | 5.72 | 3.23 | 10.64 | 3.84 |
| Balance sheet | |||||||
| Total assets | 707 | 605 | 483 | 459 | 397 | 323 | 280 |
| Net worth | 392 | 317 | 264 | 225 | 188 | 163 | 135 |
| Total debt | 311 | 284 | 217 | 232 | 207 | 159 | 143 |
| Cash & bank | 22.23 | 15.15 | 20.51 | 18.26 | 23.69 | 15.16 | 9.76 |
| Net working capital | 347 | 296 | 248 | 237 | 183 | 134 | 130 |
| Cash flow | |||||||
| Cash from operations | 78.80 | 35.40 | 69.89 | 20.36 | 15.46 | 56.18 | 38.75 |
| Cash from investing | (70.56) | (82.36) | (26.76) | (29.83) | (38.84) | (49.66) | (36.05) |
| Cash from financing | (1.16) | 41.60 | (40.87) | 4.03 | 31.92 | (1.12) | (2.67) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 375 | 318 | 277 | 277 | 288 | 285 | 259 | 269 |
| Revenue growth (YoY) | +30.3% | +11.3% | +7.2% | +2.9% | +8.6% | - | - | - |
| Other income | 1.44 | 5.90 | 2.24 | 4.91 | 15.52 | 0.28 | 2.39 | 5.29 |
| EBITDA | 52.80 | 34.23 | 25.26 | 31.97 | 31.32 | 24.81 | 24.41 | 24.03 |
| EBITDA margin | +14.1% | +10.8% | +9.1% | +11.5% | +10.9% | +8.7% | +9.4% | +8.9% |
| Depreciation | 6.32 | 5.79 | 5.40 | 5.23 | 5.08 | 4.18 | 4.34 | 4.34 |
| Interest | 6.25 | 5.66 | 5.82 | 6.06 | 6.20 | 5.67 | 5.70 | 5.56 |
| Profit before tax | 41.67 | 28.68 | 16.28 | 25.59 | 35.56 | 15.24 | 16.76 | 19.42 |
| Tax | 10.93 | 8.17 | 4.42 | 7.48 | 6.71 | 3.39 | 5.46 | 5.63 |
| Net profit | 30.74 | 20.51 | 11.86 | 18.11 | 28.85 | 11.85 | 11.30 | 13.79 |
| EPS (₹) | 4.19 | 2.73 | 1.62 | 2.50 | 3.94 | 1.68 | 1.55 | 1.91 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 1,118 | 1,057 | 925 | 922 | 780 | 539 | 472 |
| Revenue growth | +5.8% | +14.2% | +0.3% | +18.2% | +44.7% | +14.2% | - |
| EBITDA | 121 | 105 | 81.18 | 83.13 | 52.59 | 56.08 | 42.36 |
| EBITDA margin | +10.8% | +10.0% | +8.8% | +9.0% | +6.7% | +10.4% | +9.0% |
| Profit before tax | 105 | 81.88 | 59.54 | 52.63 | 35.18 | 43.07 | 18.67 |
| Net profit | 79.77 | 61.41 | 42.80 | 38.00 | 24.87 | 32.80 | 13.77 |
| Net profit margin | +7.1% | +5.8% | +4.6% | +4.1% | +3.2% | +6.1% | +2.9% |
| EPS (₹) | 10.85 | 8.46 | 6.13 | 5.37 | 3.52 | 9.33 | 4.14 |
| Balance sheet | |||||||
| Total assets | 699 | 599 | 471 | 449 | 391 | 320 | 277 |
| Net worth | 390 | 315 | 258 | 217 | 183 | 161 | 132 |
| Total debt | 306 | 280 | 212 | 230 | 206 | 158 | 142 |
| Cash & bank | 16.16 | 12.25 | 14.62 | 13.23 | 18.92 | 11.12 | 5.34 |
| Net working capital | 347 | 297 | 242 | 231 | 180 | 132 | 128 |
| Cash flow | |||||||
| Cash from operations | 73.13 | 38.63 | 69.46 | 19.17 | (7.43) | 53.27 | 37.48 |
| Cash from investing | (68.50) | (83.92) | (24.59) | (28.06) | (36.17) | (49.89) | (35.04) |
| Cash from financing | (0.72) | 42.91 | (43.74) | 3.20 | 51.40 | 2.40 | (3.65) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 367 | 311 | 269 | 267 | 271 | 278 | 256 | 268 |
| Revenue growth (YoY) | +35.6% | +11.7% | +4.8% | -0.4% | +7.1% | - | - | - |
| Other income | 1.44 | 5.82 | 2.31 | 4.76 | 15.56 | 0.42 | 2.26 | 5.26 |
| Total expenses | 315 | 277 | 243 | 233 | 244 | 255 | 227 | 242 |
| EBITDA | 51.83 | 33.96 | 25.74 | 34.13 | 27.36 | 23.58 | 29.20 | 25.99 |
| EBITDA margin | +14.1% | +10.9% | +9.6% | +12.8% | +10.1% | +8.5% | +11.4% | +9.7% |
| Depreciation | 6.14 | 5.65 | 5.27 | 5.10 | 4.96 | 4.06 | 4.25 | 4.20 |
| Interest | 6.09 | 5.53 | 5.68 | 5.92 | 6.06 | 5.56 | 5.51 | 5.41 |
| Profit before tax | 41.04 | 28.60 | 17.10 | 27.87 | 31.90 | 14.38 | 21.70 | 21.64 |
| Tax | 10.41 | 7.82 | 4.24 | 7.25 | 6.42 | 3.39 | 5.38 | 5.51 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 375 | 318 | 277 | 277 | 288 | 285 | 259 | 269 |
| Revenue growth (YoY) | +30.3% | +11.3% | +7.2% | +2.9% | +8.6% | - | - | - |
| Other income | 1.44 | 5.90 | 2.24 | 4.91 | 15.52 | 0.28 | 2.39 | 5.29 |
| EBITDA | 52.80 | 34.23 | 25.26 | 31.97 | 31.32 | 24.81 | 24.41 | 24.03 |
| EBITDA margin | +14.1% | +10.8% | +9.1% | +11.5% | +10.9% | +8.7% | +9.4% | +8.9% |
| Depreciation | 6.32 | 5.79 | 5.40 | 5.23 | 5.08 | 4.18 | 4.34 | 4.34 |
| Interest | 6.25 | 5.66 | 5.82 | 6.06 | 6.20 | 5.67 | 5.70 | 5.56 |
| Profit before tax | 41.67 | 28.68 | 16.28 | 25.59 | 35.56 | 15.24 | 16.76 | 19.42 |
| Tax | 10.93 | 8.17 | 4.42 | 7.48 | 6.71 | 3.39 | 5.46 | 5.63 |
| Net profit | 30.74 | 20.51 | 11.86 | 18.11 | 28.85 | 11.85 | 11.30 | 13.79 |
| EPS (₹) | 4.19 | 2.73 | 1.62 | 2.50 | 3.94 | 1.68 | 1.55 | 1.91 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,160 | 1,079 | 943 | 945 | 786 | 541 | 479 |
| Revenue growth | +7.5% | +14.3% | -0.2% | +20.2% | +45.4% | +12.9% | - |
| Other income | 28.57 | 15.15 | 15.70 | 4.23 | 10.36 | 8.06 | 6.58 |
| Total expenses | 1,037 | 978 | 863 | 858 | 734 | 479 | 437 |
| Employee cost | 0.00 | 50.60 | 39.61 | 32.62 | 27.57 | 23.87 | 23.82 |
| EBITDA | 123 | 101 | 80.10 | 87.12 | 52.22 | 61.33 | 42.14 |
| EBITDA margin | +10.6% | +9.4% | +8.5% | +9.2% | +6.6% | +11.4% | +8.8% |
| Depreciation | 21.49 | 17.04 | 15.27 | 17.31 | 14.09 | 11.18 | 19.52 |
| Interest | 23.74 | 22.30 | 22.26 | 17.24 | 13.97 | 9.22 | 10.86 |
| Profit before tax | 106 | 76.96 | 58.27 | 56.80 | 34.52 | 48.99 | 18.34 |
| Tax | 26.79 | 21.05 | 15.29 | 15.91 | 11.47 | 11.45 | 5.52 |
| Net profit | 79.32 | 55.27 | 41.02 | 40.42 | 22.77 | 37.42 | 12.80 |
| Net profit margin | +6.8% | +5.1% | +4.4% | +4.3% | +2.9% | +6.9% | +2.7% |
| EPS (₹) | 10.79 | 7.61 | 5.89 | 5.72 | 3.23 | 10.64 | 3.84 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 36.29 | 36.29 | 36.29 | 35.35 | 35.35 | 35.35 | 33.35 |
| Reserves & surplus | 356 | 281 | 228 | 190 | 152 | 127 | 99.51 |
| Shareholders' funds (net worth) | 392 | 317 | 264 | 225 | 188 | 163 | 135 |
| Minority interest | 1.43 | 0.65 | 0.24 | 0.44 | 0.21 | (0.37) | (0.56) |
| Secured loans | 305 | 283 | 217 | 232 | 207 | 159 | 142 |
| Unsecured loans | 5.86 | 1.85 | 0.01 | 0.00 | 0.62 | 0.06 | 0.75 |
| Total debt | 311 | 284 | 217 | 232 | 207 | 159 | 143 |
| Total liabilities | 707 | 605 | 483 | 459 | 397 | 323 | 280 |
| Assets | |||||||
| Gross block | 514 | 436 | 383 | 357 | 324 | 253 | 234 |
| Net block | 325 | 265 | 209 | 198 | 182 | 125 | 117 |
| Capital work in progress | 31.30 | 35.09 | 22.58 | 20.50 | 22.46 | 54.27 | 23.73 |
| Investments | 2.72 | 2.87 | 2.35 | 0.36 | 0.09 | 0.09 | 0.09 |
| Inventories | 178 | 140 | 114 | 136 | 123 | 87.84 | 81.78 |
| Sundry debtors | 282 | 255 | 218 | 187 | 167 | 131 | 95.77 |
| Cash & bank balances | 22.23 | 15.15 | 20.51 | 18.26 | 23.69 | 15.16 | 9.76 |
| Loans & advances | 46.42 | 53.04 | 41.96 | 31.17 | 26.71 | 30.21 | 24.01 |
| Total current assets | 528 | 463 | 394 | 373 | 340 | 265 | 211 |
| Total current liabilities | 181 | 167 | 146 | 135 | 158 | 130 | 81.19 |
| Net working capital | 347 | 296 | 248 | 237 | 183 | 134 | 130 |
| Total assets | 707 | 605 | 483 | 459 | 397 | 323 | 280 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 15.15 | 20.51 | 18.26 | 23.69 | 15.16 | 9.76 | 9.74 |
| Net cash from operating activities | 78.80 | 35.40 | 69.89 | 20.36 | 15.46 | 56.18 | 38.75 |
| Net cash from investing activities | (70.56) | (82.36) | (26.76) | (29.83) | (38.84) | (49.66) | (36.05) |
| Net cash from financing activities | (1.16) | 41.60 | (40.87) | 4.03 | 31.92 | (1.12) | (2.67) |
| Net change in cash | 7.08 | (5.36) | 2.26 | (5.44) | 8.53 | 5.40 | 0.03 |
| Closing cash | 22.23 | 15.15 | 20.51 | 18.26 | 23.69 | 15.16 | 9.76 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +7.5% | +14.3% | -0.2% | +20.2% | +45.4% | +12.9% | - |
| EBITDA growth | +21.4% | +26.3% | -8.1% | +66.8% | -14.9% | +45.5% | - |
| PBT growth | +37.9% | +32.1% | +2.6% | +64.5% | -29.5% | +167.1% | -51.7% |
| Net income growth | +43.5% | +34.7% | +1.5% | +77.5% | -39.2% | +192.3% | - |
| Revenue CAGR (3Y) | +7.1% | +11.1% | +20.4% | +25.4% | +14.2% | +15.0% | +18.9% |
| EBITDA CAGR (3Y) | +12.1% | +24.7% | +9.3% | +27.4% | -1.9% | +14.5% | +5.5% |
| Profitability & leverage | |||||||
| Net income margin | +6.8% | +5.2% | +4.6% | +4.3% | +2.9% | +7.0% | +2.7% |
| Return on capital employed | - | +18.3% | +17.1% | +17.4% | +13.5% | +19.4% | +10.9% |
| Return on net worth | - | +19.2% | +17.6% | +19.9% | +13.3% | +25.5% | +10.0% |
| Debt / equity | - | 0.86 | 0.92 | 1.07 | 1.05 | 1.03 | 1.07 |
| Long-term debt / equity | - | 0.24 | 0.24 | 0.27 | 0.30 | 0.30 | 0.24 |
| Interest cover | 23.44 | 26.51 | 34.34 | 24.70 | 36.64 | 18.38 | 48.01 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 2.64 | 2.56 | 2.79 | 2.73 | 2.23 | 2.15 |
| Inventory turnover | - | 8.50 | 7.56 | 7.32 | 7.47 | 6.37 | 6.48 |
| Debtors turnover | - | 4.57 | 4.66 | 5.33 | 5.26 | 4.76 | 4.59 |
| EPS (₹) | 10.79 | 7.61 | 5.89 | 5.72 | 3.23 | 10.64 | 3.84 |
| Dividend per share (₹) | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 1.10 | 1.00 |
| Book value per share (₹) | 0.00 | 43.65 | 36.41 | 31.68 | 26.32 | 45.67 | 39.42 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 367 | 311 | 269 | 267 | 271 | 278 | 256 | 268 |
| Revenue growth (YoY) | +35.6% | +11.7% | +4.8% | -0.4% | +7.1% | - | - | - |
| Other income | 1.44 | 5.82 | 2.31 | 4.76 | 15.56 | 0.42 | 2.26 | 5.26 |
| Total expenses | 315 | 277 | 243 | 233 | 244 | 255 | 227 | 242 |
| EBITDA | 51.83 | 33.96 | 25.74 | 34.13 | 27.36 | 23.58 | 29.20 | 25.99 |
| EBITDA margin | +14.1% | +10.9% | +9.6% | +12.8% | +10.1% | +8.5% | +11.4% | +9.7% |
| Depreciation | 6.14 | 5.65 | 5.27 | 5.10 | 4.96 | 4.06 | 4.25 | 4.20 |
| Interest | 6.09 | 5.53 | 5.68 | 5.92 | 6.06 | 5.56 | 5.51 | 5.41 |
| Profit before tax | 41.04 | 28.60 | 17.10 | 27.87 | 31.90 | 14.38 | 21.70 | 21.64 |
| Tax | 10.41 | 7.82 | 4.24 | 7.25 | 6.42 | 3.39 | 5.38 | 5.51 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,118 | 1,057 | 925 | 922 | 780 | 539 | 472 |
| Revenue growth | +5.8% | +14.2% | +0.3% | +18.2% | +44.7% | +14.2% | - |
| Other income | 28.45 | 14.86 | 15.05 | 3.63 | 10.28 | 7.11 | 6.39 |
| Total expenses | 997 | 951 | 844 | 839 | 728 | 483 | 430 |
| Employee cost | 0.00 | 44.53 | 36.44 | 31.83 | 26.97 | 23.45 | 23.40 |
| EBITDA | 121 | 105 | 81.18 | 83.13 | 52.59 | 56.08 | 42.36 |
| EBITDA margin | +10.8% | +10.0% | +8.8% | +9.0% | +6.7% | +10.4% | +9.0% |
| Depreciation | 20.97 | 16.57 | 14.99 | 17.12 | 13.96 | 11.06 | 19.43 |
| Interest | 23.19 | 21.70 | 21.70 | 17.01 | 13.73 | 9.06 | 10.65 |
| Profit before tax | 105 | 81.88 | 59.54 | 52.63 | 35.18 | 43.07 | 18.67 |
| Tax | 25.72 | 20.48 | 15.04 | 14.61 | 10.27 | 10.09 | 4.89 |
| Net profit | 79.77 | 61.41 | 42.80 | 38.00 | 24.87 | 32.80 | 13.77 |
| Net profit margin | +7.1% | +5.8% | +4.6% | +4.1% | +3.2% | +6.1% | +2.9% |
| EPS (₹) | 10.85 | 8.46 | 6.13 | 5.37 | 3.52 | 9.33 | 4.14 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 36.29 | 36.29 | 36.29 | 35.35 | 35.35 | 35.35 | 33.35 |
| Reserves & surplus | 354 | 279 | 221 | 182 | 148 | 125 | 97.10 |
| Shareholders' funds (net worth) | 390 | 315 | 258 | 217 | 183 | 161 | 132 |
| Secured loans | 300 | 278 | 212 | 230 | 206 | 156 | 142 |
| Unsecured loans | 5.86 | 1.85 | 0.01 | 0.00 | 0.00 | 2.93 | 0.00 |
| Total debt | 306 | 280 | 212 | 230 | 206 | 158 | 142 |
| Total liabilities | 699 | 599 | 471 | 449 | 391 | 320 | 277 |
| Assets | |||||||
| Gross block | 503 | 428 | 377 | 352 | 322 | 251 | 232 |
| Net block | 315 | 257 | 203 | 194 | 180 | 123 | 115 |
| Capital work in progress | 29.98 | 32.27 | 19.30 | 17.54 | 19.67 | 53.70 | 23.73 |
| Investments | 5.40 | 5.59 | 5.06 | 3.07 | 2.81 | 2.81 | 1.13 |
| Inventories | 152 | 119 | 99.11 | 114 | 98.01 | 77.21 | 76.10 |
| Sundry debtors | 307 | 276 | 222 | 202 | 185 | 133 | 107 |
| Cash & bank balances | 16.16 | 12.25 | 14.62 | 13.23 | 18.92 | 11.12 | 5.34 |
| Loans & advances | 38.94 | 44.91 | 45.31 | 32.81 | 24.69 | 31.37 | 27.17 |
| Total current assets | 514 | 452 | 381 | 362 | 327 | 253 | 216 |
| Total current liabilities | 166 | 155 | 140 | 132 | 146 | 121 | 88.29 |
| Net working capital | 347 | 297 | 242 | 231 | 180 | 132 | 128 |
| Total assets | 699 | 599 | 471 | 449 | 391 | 320 | 277 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 12.25 | 14.62 | 13.49 | 18.92 | 11.12 | 5.34 | 6.54 |
| Net cash from operating activities | 73.13 | 38.63 | 69.46 | 19.17 | (7.43) | 53.27 | 37.48 |
| Net cash from investing activities | (68.50) | (83.92) | (24.59) | (28.06) | (36.17) | (49.89) | (35.04) |
| Net cash from financing activities | (0.72) | 42.91 | (43.74) | 3.20 | 51.40 | 2.40 | (3.65) |
| Net change in cash | 3.91 | (2.37) | 1.13 | (5.68) | 7.80 | 5.78 | (1.20) |
| Closing cash | 16.16 | 12.25 | 14.62 | 13.23 | 18.92 | 11.12 | 5.34 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +5.8% | +14.2% | +0.3% | +18.2% | +44.7% | +14.2% | - |
| EBITDA growth | +15.1% | +29.7% | -2.4% | +58.1% | -6.2% | +32.4% | - |
| PBT growth | +28.8% | +37.5% | +13.1% | +49.6% | -18.3% | +130.7% | -48.7% |
| Net income growth | +29.9% | +43.5% | +12.6% | +52.8% | -24.2% | +138.2% | - |
| Revenue CAGR (3Y) | +6.6% | +10.6% | +19.7% | +25.0% | +14.0% | +15.8% | +19.4% |
| EBITDA CAGR (3Y) | +13.4% | +26.0% | +13.1% | +25.2% | -0.6% | +13.1% | +7.6% |
| Profitability & leverage | |||||||
| Net income margin | +7.1% | +5.8% | +4.8% | +4.1% | +3.2% | +6.1% | +2.9% |
| Return on capital employed | - | +19.4% | +17.7% | +16.6% | +13.8% | +17.5% | +11.1% |
| Return on net worth | - | +21.5% | +18.8% | +19.1% | +14.6% | +22.7% | +10.9% |
| Debt / equity | - | 0.86 | 0.93 | 1.10 | 1.07 | 1.03 | 1.08 |
| Long-term debt / equity | - | 0.23 | 0.24 | 0.27 | 0.30 | 0.30 | 0.24 |
| Interest cover | 23.14 | 24.46 | 32.78 | 25.77 | 35.54 | 20.12 | 46.45 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 2.63 | 2.54 | 2.75 | 2.74 | 2.25 | 2.13 |
| Inventory turnover | - | 9.68 | 8.68 | 8.69 | 8.91 | 7.04 | 6.83 |
| Debtors turnover | - | 4.24 | 4.36 | 4.76 | 4.90 | 4.49 | 4.21 |
| EPS (₹) | 10.85 | 8.46 | 6.13 | 5.37 | 3.52 | 9.33 | 4.14 |
| Dividend per share (₹) | 0.50 | 0.50 | 0.50 | 0.50 | 0.50 | 1.10 | 1.00 |
| Book value per share (₹) | 0.00 | 43.42 | 35.45 | 30.54 | 25.69 | 45.08 | 38.70 |
To see the full year-wise statements and ratios of Indo Amines Limited, buy the company report.
Board of directors and KMP of Indo Amines Limited
Indo Amines Limited currently reports 15 directors and 2 key managerial personnel. 24 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Sharad Chitnis | Additional Director | 15 Jul 2026 | 0 Years 3 Months | Current |
| Suniti Sagar Thombre | Cfo | 10 Nov 2023 | 2 Years 11 Months | Current |
| Satish Madhukar Chitale | Director | 30 May 2018 | 8 Years 4 Months | Current |
| Adhikrao Abaji Shingade | Whole-Time Director | 28 Jun 2021 | 5 Years 3 Months | Current |
| Tripti Mahesh Sharma Also directs: United Vander Horst Ltd, Max Spare Limited | Company Secretary | 15 Feb 2016 | 10 Years 8 Months | Current |
| Dhawal Jitendra Vora | Director | 10 Aug 2023 | 3 Years 2 Months | Current |
Peer comparison
Indo Amines Limited is compared with the 9 companies closest to it by revenue in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Grauer and Weil (India) Limited | ₹1,180.04 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India | |||
| Hemani Industries Limited | ₹1,166.06 Cr (FY 2025) | 2.0% | Mumbai, Maharashtra, India | |||
| Indo Amines Limitedthis company | ₹1,159.66 Cr (FY 2026) | ₹79.32 Cr | 6.8% | 7.5% | 558 | Thane, Maharashtra, India |
| Sami-Sabinsa Group Limited | ₹1,137 Cr (FY 2025) | -6.0% | Bangalore, Karnataka, India | |||
| PCBL (TN) Limited | ₹1,136.78 Cr (FY 2025) | 122.0% | Kolkata, West Bengal, India | |||
| Gacl-Nalco Alkalies & Chemicals Private Limited | ₹1,089.97 Cr (FY 2025) | 37.0% | Vadodara, Gujarat, India | |||
| Performance Specialty Products (India) Private Limited | ₹1,082.8 Cr (FY 2025) | 5.0% | Gurgaon, Haryana, India | |||
| Acutaas Chemicals Limited | ₹1,023.8 Cr (FY 2025) | 41.0% | Surat, Gujarat, India | |||
| Prasol Chemicals Limited | ₹1,015.53 Cr (FY 2025) | 14.0% | Navi Mumbai, Maharashtra, India | |||
| Cohizon Life Sciences Limited | ₹1,008.66 Cr (FY 2025) | -9.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Indo Amines Limited, buy the company report.
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 58.40%, foreign institutional investors hold 0.10%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 41.50%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 58.40% | 58.40% | 58.40% | 58.40% |
| Public | 41.60% | 41.60% | 41.60% | 41.60% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Aug 2026 | 101376022 | Others | ₹15.5 Lakh | Open | |
| 20 May 2026 | 101300988 | Hdfc Bank Limited | ₹28 Cr | Open | |
| 27 Apr 2026 | 101289681 | Hdfc Bank Limited | ₹19.39 Lakh | Open | |
| 27 Apr 2026 | 101290310 | Hdfc Bank Limited | ₹19.39 Lakh | Open | |
| 22 Mar 2026 | 101265586 | Citi Bank N.A. | ₹15 Cr | Open |
To see the full charge records of Indo Amines Limited, buy the company report.
Total charge records: 92 View all charges
Deals & funding
Indo Amines Limited has 11 deals on record (11 market trades); the latest was in December 2024.
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2024 | Market trade | ₹7.3 Cr | Buyer: Hrti Private Limited Seller: Hrti Private Limited |
| Sep 2024 | Market trade | ₹71.17 Cr | Buyer: Hrti Private Limited , Aakraya Research LLP , Graviton Research Capital LLP Seller: Hrti Private Limited , Aakraya Research LLP , Graviton Research Capital LLP |
| Sep 2024 | Market trade | ₹7.81 Cr | Buyer: Graviton Research Capital LLP Seller: Graviton Research Capital LLP |
| Aug 2024 | Market trade | ₹10.06 Cr | Buyer: Graviton Research Capital LLP Seller: Graviton Research Capital LLP |
| Aug 2024 | Market trade | ₹9.48 Cr | Buyer: Graviton Research Capital LLP Seller: Graviton Research Capital LLP |
To see the full deal history of Indo Amines Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Indo Amines Limited has 159 court cases on record: 88 filed by Indo Amines, 72 filed against it. 62 cases are pending and 97 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 137 | 67 | 58 |
| High courts | 18 | 5 | 2 |
| Supreme Court | 2 | 0 | 2 |
| NCLT | 2 | 0 | 0 |
Cases on record (5 of 159)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Court case (Sum.Civ.Suit) | Filed by the company against M/S Super Crop Safe Ltd | Pending |
| District court, Thane, Maharashtra | Civil suit | Filed by the company against Formel Labs Private Limited | Pending |
| District court, Thane, Maharashtra | Civil suit | Filed by the company against Colorchem Industries Limited | Pending |
| District court, Thane, Maharashtra | Civil suit | Filed against the company by Indo Amines Ltd Through Its Authorized Representative Mr Kedar Shashikant Chavan | Pending |
| District court, Thane, Maharashtra | Civil suit | Filed by the company against Synaptics Labs Private Limited | Pending |
To see the full case history of Indo Amines Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Indo Amines Limited was last rated by Crisil on 23 Oct 2019.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 23 Oct 2019 |
To see the full credit ratings and regulatory alerts of Indo Amines Limited, buy the company report.
MSME payment delays
Indo Amines Limited has 14 MSME Form 1 returns on record between 2019 and 2024, listing 1,204 overdue payments to 72 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 72)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| Recycling Solutions Private Limited | |||
| Om Air |
To see the full MSME payment records of Indo Amines Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Indo Amines has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Indo Speciality Chemicals Private Limited | U74999MH1986PTC039446 |
To see the full group structure of Indo Amines Limited, buy the company report.
Employees & EPFO
Indo Amines Limited has a workforce of 558 employees on its EPFO records as of Oct 01, 2024, across 2 active EPFO establishments.
GST
Indo Amines has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACI1374A1Z3 | Maharashtra | Active | 01 Jul 2017 |
| 24AAACI1374A1Z9 | Gujarat | Active | 01 Jul 2017 |
| 29AAACI1374A1ZZ | Karnataka | Active | 01 Dec 2017 |
To see the full GST registrations and return filing status of Indo Amines Limited, buy the company report.
Recent activity
Indo Amines Limited has 38 board changes on record since 1994: 17 appointments and 21 cessations. The latest: Rahul Sharad Chitnis was appointed as Additional Director on 15 Jul 2026.
202 earlier events are in the company report.
News
Frequently asked questions
Indo Amines is an active public limited company based in Thane, Maharashtra, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 17 December 1992 (34+ years old) and is registered under CIN L99999MH1992PLC070022. Listed on BSE: 524648 and NSE: INDOAMIN.
Indo Amines reported revenue of ₹1,159.66 Cr for FY 2025-26 (up 7.5% YoY) based on consolidated financials.
Indo Amines has 17 current directors and KMP:
- Vijay Bhalchandra Palkar - Managing Director
- Rahul Vijay Palkar - Managing Director
- Adhikrao Abaji Shingade - Whole-Time Director
- Saji Jose - Whole-Time Director
- Bharati Vijay Palkar - Whole-Time Director
- Jayaprakash Anand Shetty - Whole-Time Director
- Rahul Sharad Chitnis - Additional Director
- Satish Madhukar Chitale - Director
- Dhawal Jitendra Vora - Director
- Pradeep Hari Thakur - Director
- Avinash Krishna Aphale - Director
- Vijay Yeshwant Sane - Director
- Rohan Rajeev Deshpande - Director
- Ajay Marathe - Director
- Tejaswini Shirish Dalvi - Director
- Suniti Sagar Thombre - Cfo
- Tripti Mahesh Sharma - Company Secretary
The latest financial statements of Indo Amines on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 24 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Indo Amines is 27AAACI1374A1Z3, registered in Maharashtra. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 24AAACI1374A1Z9 (Gujarat), 29AAACI1374A1ZZ (Karnataka).
The CIN (Corporate Identification Number) of Indo Amines is L99999MH1992PLC070022. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Indo Amines is a listed company as per MCA records. Its shares are listed on both BSE (code: 524648) and NSE (symbol: INDOAMIN).
Indo Amines has 159 court cases on record: 88 filed by the company and 72 filed against it. 62 are pending. Most are in the district courts.
Indo Amines was incorporated on 17 December 1992, making it 34+ years old. It is registered with the Registrar of Companies, Mumbai.
Indo Amines has 11 deals on record (11 market trades); the latest was in December 2024.
The peers of Indo Amines by revenue are Grauer and Weil (India) Limited, Hemani Industries Limited, Sami-Sabinsa Group Limited, PCBL (TN) Limited, Gacl-Nalco Alkalies & Chemicals Private Limited and 4 more, all in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rahul Sharad Chitnis was appointed as Additional Director on 15 Jul 2026. Tejaswini Shirish Dalvi was appointed as Director on 29 May 2025. Saji Jose was appointed as Whole-Time Director on 01 Jun 2024. Indo Amines has 38 board changes on record in total.